Filing Flows › 10x Genomics (TXG) › Q2 2026 › vs Q1 2026
10x Genomics (TXG) Q2 2026 vs Q1 2026 (quarter over quarter)
10x Genomics's revenue rose $193K (+0.1%) from $151M in Q1 2026 to $151M in Q2 2026. The biggest changes: License and royalty revenue +$995K (+105%); Products and services revenue −$802K (-0.5%).
10x Genomics, Q2 2026: revenue $151M (-13% year over year), operating margin -12.9%, net loss $17.9M, operating cash flow $17.0M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Free cash flow margin | 10.2% | 16.3% | -6.1 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Single Cell | $88.5M | $88.9M | −$443K | -0.5% |
| Spatial | $42.3M | $40.9M | $1.4M | +3% |
| Services | $10.7M | $8.8M | $1.8M | +21% |
| Spatial | $4.6M | $6.0M | −$1.5M | -24% |
| Single Cell | $3.1M | $5.2M | −$2.1M | -41% |
| Products and services revenue | $149M | $150M | −$802K | -0.5% |
| License and royalty revenue | $1.9M | $947K | $995K | +105% |
| Revenue | $151M | $151M | $193K | +0.1% |
| Other income, net | $910K | $4.2M | −$3.3M | -78% |
| Income tax benefit | $714K | −$623K | $1.3M | — |
| Net loss | $17.9M | $13.5M | $4.5M | +33% |
| Costs & expenses | $171M | $169M | $2.1M | +1% |
| Operating costs | $171M | $168M | $2.7M | +2% |
| Cost of revenue | $38.5M | $44.7M | −$6.1M | -14% |
| Operating expenses | $132M | $123M | $8.8M | +7% |
| Operating cash sources | $35.3M | $32.6M | $2.7M | +8% |
| Depreciation & amortization | $9.7M | $10.0M | −$293K | -3% |
| Share-based compensation | $25.6M | $22.6M | $3.0M | +13% |
| Net loss absorbed | $17.9M | $13.5M | $4.5M | +33% |
| Working capital & other | $375K | −$7.0M | $7.4M | — |
| Operating cash flow | $17.0M | $26.1M | −$9.1M | -35% |
| Free cash flow (OCF − capex) | $15.4M | $24.5M | −$9.1M | -37% |
| Capital expenditures | $1.6M | $1.6M | −$9K | -0.6% |
Questions
How much did 10x Genomics's revenue grow quarter over quarter in Q2 2026?
10x Genomics's revenue rose $193K (+0.1%) from $151M in Q1 2026 to $151M in Q2 2026.
What drove 10x Genomics's revenue change in Q2 2026?
License and royalty revenue +$995K (+105%); Products and services revenue −$802K (-0.5%).